Meda AB (publ.) January - June 2007, H1 Interim Report - Genetic Engineering News (press release)
Meda AB (publ.) January - June 2007, H1 Interim ReportGenetic Engineering News (press release), NY - Aug 8, 2007Its bestsellers are Astelin and Optivar, containing the active substance azelastine. Astelin is a steroid-free nasal spray, approved for treatment of …
Read full story